Skip To Main Content

This website is intended exclusively for healthcare professionals residing and/or working in Oman.

Atherothrombosis

Discover more on science updates, events, KOLs interviews and more on Atherothrombosis

Science in Atherothrombosis

Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Smart-choice trial_P2Y12 inhibitor monotherapy in complex PCI

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

Ticagrelor vs Clopidogrel in high bleeding risk patients with ACS

In hospital outcomes in young patients with AMI: Results from Gulf Coast

In hospital outcomes in young patients with AMI: Results from Gulf Coast

Adherence and persistence analysis in patients treated with DAPT

Adherence and persistence analysis in patients treated with DAPT

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

P2Y12 inhibitor adherence trajectories in ACS

P2Y12 inhibitor adherence trajectories in ACS

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?

Inspiration and innovation

Get inspired and stay at the forefront of innovation with the following resources